Cboe UK EUR

Merck & Co., Inc. (6MKD.XC)

70.20

+2.50

+(3.69%)

As of 8:25:32 AM GMT+1. Market Open.

Merck warns of big tariff hit, Hasbro soars, Comcast sinks

Julie Hyman provides an overview of the top stories of the trading day in just 60 seconds on Yahoo Finance's Market Minute. Merck & Company (MRK) warns investors that it expects a $200 million hit from tariffs. Hasbro (HAS) stock is soaring after reporting a first quarter earnings beat. Comcast (CMCSA) stock sinks after reporting a larger-than-expected loss in broadband customers. Stay up to date on the latest market action, minute-by-minute, with Yahoo Finance's Market Minute.

Yahoo Finance Video 19 hours ago

MRK

HAS

CMCSA
Merck, Nokia, Texas Instruments: Trending Tickers

Brad Smith and Madison Mills take a closer look at some of today's trending tickers ahead of the opening bell on Wall Street. Merck (MRK) lowers its 2025 profit outlook as the drugmaker expects a $200 million tariff hit. Nokia (NOK) warns of an earnings hit from tariffs in the second quarter after the company's first quarter earnings fell short of Wall Street's expectations. Texas Instruments (TXN) issues a strong outlook alongside its earnings beat as demand rebounds. To watch more expert insights and analysis on the latest market action, check out more Morning Brief here.

Yahoo Finance Video 22 hours ago

TXN

MRK

NOK
Q1 2025 Merck & Co Inc Earnings Call

Q1 2025 Merck & Co Inc Earnings Call

Thomson Reuters StreetEvents 7 hours ago

MRK
Stocks to Watch Recap: Alphabet, Intel, P&G, Merck

🔎 After-Hours Earnings: Shares of Google-parent Alphabet and Gilead Sciences rose after earnings releases late Wednesday, while shares of Intel, T-Mobile and Skechers fell. ↘️ IBM (IBM): The tech company warned that macroeconomic uncertainty was prompting businesses to rethink spending.

The Wall Street Journal 14 hours ago

MRK

NOW

TSLA
Merck Stock Reverses, Though Gardasil 'Woes' Continue In China, Japan

Merck stock reversed higher Thursday, though the company reported another quarter of light sales for its HPV vaccine, Gardasil.

Investor's Business Daily 16 hours ago

MRK
Merck Q1 Earnings & Sales Beat Estimates, '25 EPS Outlook Cut

MRK posts better-than-expected first-quarter results but trims its 2025 EPS outlook due to anticipated one-time charges.

Zacks 18 hours ago

MRK
Merck (NYSE:MRK) Faces Patent Lawsuit As Earnings Grow US$317 Million In Q1

Merck (NYSE:MRK) experienced a 2.98% share price increase over the past week, during which several key developments occurred. The company reaffirmed its 2025 financial guidance, despite a slight decline in Q1 sales and ongoing patent litigation with Halozyme Therapeutics. Meanwhile, broader market movements, boosted by a tech-driven rally and anticipation of tariff news, provided a favorable backdrop. The market, seeing an overall 2.3% increase, suggested positive sentiment, possibly...

Simply Wall St. 18 hours ago

MRK
Merck Cuts 2025 Outlook on Tariffs, Charges

Merck’s first-quarter net income increased as sales of its Keytruda cancer drug rose, but the Big Pharma company cut its 2025 adjusted earnings projection, partly to account for recently imposed tariffs.

The Wall Street Journal 20 hours ago

MRK
Merck takes $200M tariff hit, trimming its gross profits

The drugmaker absorbed additional tariff-related costs in the first quarter, but has taken steps to lower the financial impact it’ll have for the rest of the year and beyond.

BioPharma Dive yesterday

MRK
Merck’s (NYSE:MRK) Q1 Sales Beat Estimates

Global pharmaceutical company Merck (NYSE:MRK) beat Wall Street’s revenue expectations in Q1 CY2025, but sales fell by 1.6% year on year to $15.53 billion. The company expects the full year’s revenue to be around $64.85 billion, close to analysts’ estimates. Its non-GAAP profit of $2.22 per share was 4% above analysts’ consensus estimates.

StockStory yesterday

MRK
Merck: Q1 Earnings Snapshot

RAHWAY, N.J. (AP) — Merck & Co. (MRK) on Thursday reported first-quarter earnings of $5.08 billion. On a per-share basis, the Rahway, New Jersey-based company said it had profit of $2.01. Earnings, adjusted for one-time gains and costs, came to $2.22 per share.

Associated Press Finance yesterday

MRK
Merck Announces First-Quarter 2025 Financial Results

RAHWAY, N.J., April 24, 2025--Merck Announces First-Quarter 2025 Financial Results

Business Wire yesterday

MRK
Alphabet earnings, Fed comments, Nintendo Switch 2: What to Watch

Here's what investors are watching on Thursday, April 24. Procter & Gamble (PG), Merck (MRK), and PepsiCo (PEP) are set to release quarterly results before the opening bell, while Alphabet (GOOG, GOOGL), T-Mobile (TMUS), and Intel (INTC) are on deck to report after the market close. Minneapolis Federal Reserve President Neel Kashkari will deliver remarks. Nintendo (NTDOY, 7974.T) will kick off Switch 2 pre-orders in the US and Canada. To watch more expert insights and analysis on the latest market action, check out more Market Domination Overtime here.

Yahoo Finance Video yesterday

GOOG

PEP

TMUS
BioNTech Surges On Summit's Coattails. But Can They Take On Merck?

BioNTech stock rocketed Wednesday after rival Summit Therapeutics unveiled promising results for a novel approach to lung cancer treatment.

Investor's Business Daily yesterday

BNTX

MRK

SMMT
Why vaccine makers aren't worried about Trump administration cuts

Vaccines have been a central focus for Trump's health leaders, but large-cap players aren't feeling the sting.

Yahoo Finance yesterday

MRNA

MRK

SNY
Is Merck & Co., Inc. (MRK) the Best Stock To Buy According to Marjorie Taylor Greene?

We recently published a list of 20 Best Stock To Buy According to Marjorie Taylor Greene. In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against other stocks to buy according to Marjorie Taylor Greene. Marjorie Taylor Greene is one of the most active members of […]

Insider Monkey yesterday

MRK
Merck (MRK) Reports Q1: Everything You Need To Know Ahead Of Earnings

Global pharmaceutical company Merck (NYSE:MRK) will be reporting results tomorrow before market hours. Here’s what to expect.

StockStory 2 days ago

MRK
Merck & Co., Inc. (MRK): Among Prem Watsa’s Stock Picks With Highest Potential

We recently compiled a list of Billionaire Prem Watsa’s 10 Stock Picks With Highest Potential. In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against Prem Watsa’s other stock picks. Momentum and technology stocks have dominated the markets over the past decade. They have been the catalyst […]

Insider Monkey 2 days ago

MRK

FAXRF
Merck Q1 Earnings Coming Up: Should You Buy the Stock Now?

When Merck reports first-quarter earnings, investors are likely to focus on the sales of its blockbuster oncology medicine, Keytruda.

Zacks 3 days ago

MRK
Health Canada Approves KEYTRUDA® Plus Pemetrexed and Platinum Chemotherapy as First-Line Treatment for Adult Patients with Unresectable Advanced or Metastatic Malignant Pleural Mesothelioma (MPM)

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that Health Canada has approved KEYTRUDA® (pembrolizumab), Merck's anti-PD-1 therapy, in combination with pemetrexed and platinum chemotherapy, for the first-line treatment of adult patients with unresectable advanced or metastatic malignant pleural mesothelioma (MPM). The approval is based on data from the pivotal Phase 3 IND.227/KEYNOTE-483 trial, which demonstrated a statistically significant improvement

CNW Group 3 days ago

MRK

Performance Overview

Return	6MKD.XC	S&P 500 (^GSPC)
YTD	-26.79%	-6.75%
1-Year	-34.73%	+8.64%
3-Year	-28.95%	+27.67%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Merck & Co., Inc. (6MKD.XC)

Merck warns of big tariff hit, Hasbro soars, Comcast sinks

Merck, Nokia, Texas Instruments: Trending Tickers

Q1 2025 Merck & Co Inc Earnings Call

Stocks to Watch Recap: Alphabet, Intel, P&G, Merck

Merck Stock Reverses, Though Gardasil 'Woes' Continue In China, Japan

Merck Q1 Earnings & Sales Beat Estimates, '25 EPS Outlook Cut

Merck (NYSE:MRK) Faces Patent Lawsuit As Earnings Grow US$317 Million In Q1

Merck Cuts 2025 Outlook on Tariffs, Charges

Merck takes $200M tariff hit, trimming its gross profits

Merck’s (NYSE:MRK) Q1 Sales Beat Estimates

Merck: Q1 Earnings Snapshot

Merck Announces First-Quarter 2025 Financial Results

Alphabet earnings, Fed comments, Nintendo Switch 2: What to Watch

BioNTech Surges On Summit's Coattails. But Can They Take On Merck?

Why vaccine makers aren't worried about Trump administration cuts

Is Merck & Co., Inc. (MRK) the Best Stock To Buy According to Marjorie Taylor Greene?

Merck (MRK) Reports Q1: Everything You Need To Know Ahead Of Earnings

Merck & Co., Inc. (MRK): Among Prem Watsa’s Stock Picks With Highest Potential

Merck Q1 Earnings Coming Up: Should You Buy the Stock Now?

Health Canada Approves KEYTRUDA® Plus Pemetrexed and Platinum Chemotherapy as First-Line Treatment for Adult Patients with Unresectable Advanced or Metastatic Malignant Pleural Mesothelioma (MPM)

Performance Overview